A new drug that gives almost complete protection against the virus was to be administered across Africa this year. Now, much of the funding for that effort is gone.
Tag: Gates, Bill and Melinda, Foundation
Promise of Victory Over H.I.V. Fades as U.S. Withdraws Support
A new drug that gives almost complete protection against the virus was to be administered across Africa this year. Now, much of the funding for that effort is gone.
Promise of Victory Over H.I.V. Fades as U.S. Withdraws Support
A new drug that gives almost complete protection against the virus was to be administered across Africa this year. Now, much of the funding for that effort is gone.
Sugary Drinks Linked to Global Rise in Diabetes, Heart Disease
A new study assesses the effects of sugar-laden beverages on global health, with higher rates of consumption found in Latin America and parts of Africa.
Malaria Vaccine Rollout to Africa Is a Cautionary Tale
After years of delay, millions of malaria vaccines are being supplied to children in Africa. Tens of thousands died waiting.
More Women in Africa Are Using Long-Acting Contraception, Changing Lives
Methods such as hormonal implants and injections are reaching remote areas, providing more discretion and autonomy.
Inside the Factory Supplying Half of Africa’s Syringes
In Kenya, Revital Healthcare is manufacturing medical products that Africa needs to take charge of routine health care and respond to outbreaks.
‘Only God Can Thank You’: Female Health Workers Fight to Be Paid
Community health workers put in long hours to protect people in developing countries from diseases such as malaria, Covid-19 and H.I.V. But most are compensated minimally, or not paid at all.
Scientists Boost Soy Crops Through Improved Photosynthesis
Researchers increased yield in soy plants by making them better at photosynthesis, the process that powers life. The findings hold promise for feeding a warming world.
Gates Foundation Pledges $120 Million to Help Get Merck Covid Pills to Poor Countries
Regulatory hurdles and supply chain issues could slow efforts to produce generic versions of Merck’s antiviral molnupiravir for developing nations, despite licensing agreements.